Literature DB >> 21993388

Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?

Z Rezaieyazdi1, M Sahebari, M R Hatef, B Abbasi, H Rafatpanah, J Tavakol Afshari, H Esmaily.   

Abstract

The role of C-reactive protein (CRP) in systemic lupus erythematosus (SLE) as an inflammatory marker is still controversial. Recently, more sensitive methods, such as high sensitive CRP (hs-CRP) have been used to detect micro-inflammation. The role of hs-CRP in lupus flare has not been documented well. We conducted this study to examine the correlation between hs-CRP serum concentrations and disease activity in lupus. Ninety-two SLE patients and 49 healthy controls contributed to our study. Most confounding factors influencing the hs-CRP values were excluded. Disease activity was estimated using the SLE Disease Activity Index (SLEDAI-2K). hs-CRP values were determined using an enzyme-linked immunosorbent assay (ELISA) kit. Serum values of hs-CRP were significantly higher (p < 0.001, z = 3.29) in patients compared with healthy controls. The cutoff point for hs-CRP between patients and controls was 0.93 mg/L (Youden's Index = 0.39). There was no correlation between hs-CRP serum levels and disease activity. Furthermore, hs-CRP values did not correlate with any of the laboratory parameters, except for C3 (p = 0.003, r(s)  = -0.2) and C4 (p = 0.02, r(s) = -0.1). Although hs-CRP serum levels were significantly higher in lupus patients compared with healthy controls, it seems that this marker is not a good indicator for disease activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993388     DOI: 10.1177/0961203311418706

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

2.  Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy.

Authors:  Cristiana Fabbri; Ricardo Fuller; Eloisa Bonfá; Lissiane K N Guedes; Paulo Sergio R D'Alleva; Eduardo F Borba
Journal:  Clin Rheumatol       Date:  2014-01-11       Impact factor: 2.980

3.  Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus.

Authors:  James S Andrews; Laura Trupin; Catherine L Hough; David I Daikh; Edward H Yelin; Patricia P Katz
Journal:  Cytokine       Date:  2016-11-16       Impact factor: 3.861

4.  Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Authors:  L Wirestam; H Enocsson; T Skogh; M L Eloranta; L Rönnblom; C Sjöwall; J Wetterö
Journal:  Clin Exp Immunol       Date:  2017-03-31       Impact factor: 4.330

Review 5.  C-reactive protein and the biology of disease.

Authors:  Waliza Ansar; Shyamasree Ghosh
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

6.  The role of serum C-reactive protein measured by high-sensitive method in thyroid disease.

Authors:  Agata Czarnywojtek; Maciej Owecki; Małgorzata Zgorzalewicz-Stachowiak; Kosma Woliński; Ewelina Szczepanek-Parulska; Bartłomiej Budny; Ewa Florek; Joanna Waligórska-Stachura; Izabela Miechowicz; Maciej Bączyk; Nadia Sawicka; Sumit Dhir; Marek Ruchała
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-05-04       Impact factor: 4.291

7.  Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.

Authors:  Vinod Umare; Vandana Pradhan; Milind Nadkar; Anjali Rajadhyaksha; Manisha Patwardhan; Kanjaksha K Ghosh; Anita H Nadkarni
Journal:  Mediators Inflamm       Date:  2014-12-07       Impact factor: 4.711

8.  Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?

Authors:  V Umare; A Nadkarni; M Nadkar; A Rajadhyksha; P Khadilkar; K Ghosh; V D Pradhan
Journal:  J Postgrad Med       Date:  2017 Apr-Jun       Impact factor: 1.476

9.  The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.

Authors:  D Jiménez-Gallo; R de la Varga-Martínez; L Ossorio-García; C Albarrán-Planelles; C Rodríguez; M Linares-Barrios
Journal:  Mediators Inflamm       Date:  2017-07-10       Impact factor: 4.711

10.  Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Authors:  Marzena Ciechomska; Krzysztof Bonek; Michal Merdas; Patryk Zarecki; Jerzy Swierkot; Piotr Gluszko; Katarzyna Bogunia-Kubik; Wlodzimierz Maslinski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-05-09       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.